<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-pathogens-08-00176">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Terrier</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Launay</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Kaplanski</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Hot</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Larroche</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Cath√©bras</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Combe</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>De Jaureguiberry</surname>
    <given-names>J.P.</given-names>
   </name>
   <name>
    <surname>Meyer</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Schaeverbeke</surname>
    <given-names>T.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis, data from the French Autoimmunity and Rituximab registry</article-title>
  <source>Arthritis Care Res.</source>
  <year>2010</year>
  <volume>62</volume>
  <fpage>1787</fpage>
  <lpage>1795</lpage>
  <pub-id pub-id-type="doi">10.1002/acr.20318</pub-id>
 </element-citation>
</ref>
